A senior executive of Janssen’s supply chain leadership team outlines how the company handled activities in Asia Pacific at the height of the coronavirus outbreak, including ensuring continuous and rapid supplies of critical medicines in China. The company is also prepping against “multiple scenarios” to ensure global access for its potential COVID-19 vaccine.
If supply chain and logistics teams in pharma were traditionally seen as behind-the-scenes operations types, then the coronavirus pandemic has changed that dramatically, putting these functions front and center.
As global supply chain networks tottered during the early days of COVID-19, senior executives had to juggle multiple priorities while...